The study, conducted by researchers with the Centers for Disease Control and Prevention (CDC), found that six bacterial ...

Medical honey proves effective against antibiotic-resistant bacteria, transforming wound care and offering hope in the fight ...

Few patients tested positive for VRE overall, so the authors said more ... hospitalized children without prior VRE colonization or infection. The authors performed systematic VRE screening before ...

Acurx Pharmaceuticals, Inc. ("we" or "Acurx" or the "Company"), a late-stage biopharmaceutical company developing a new class of antibiotics for difficult-to-treat bacterial infections, today ...

difficile Infection (CDI). The Company today announced ... aureus (MRSA), vancomycin resistant Enterococcus (VRE), drug- resistant Streptococcus pneumoniae (DRSP) and B.

Acurx's lead product candidate, ibezapolstat, for the treatment of C. difficile Infection is Phase 3 ready with plans in progress to begin international clinical trials this year. The Company's ...

VRE=vancomycin-resistant enterococci ... 58 We suggest that the outcomes of MDRO decolonisation and infection should be analysed separately, particularly since the outcomes of MDRO infection may be ...

August 22 Alice is discharged from the hospital to Hospice. August 24 Upon arrival at Hospice, Alice has MRSA, a UTI, C. diff, and VRE, an often fatal infection. August 29 Alice dies of sepsis at ...